Medicines update

VTE risk the same, regardless of oral contraceptive

A recent study has reconfirmed that there is no significant difference in the risk of adverse effects when taking drospirenone pills, compared to other regularly prescribed oral contraceptives.

In an editorial published in the journal Contraception, Dr Robert Reid of Queen’s University in Ontario, Canada, said that pregnancy increases the risk of venous thromboembolism (VTE) 5-10-fold above the risk in the non